Search results
Arcellx shares target raised by Stifel on study design By Investing.com
Investing.com· 6 days agoThe adjustment follows the company's announcement regarding the design of a phase 3 study for...
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the...
WPRI Providence· 1 day agoHaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg ...
Doubt Cast on MGUS-Autoimmune Disease Link
MedPage Today· 2 days agoContrary to earlier studies, the not-entirely-rare condition known as monoclonal gammopathy of undetermined significance (MGUS) did not appear to raise...
FDA approves Amgen drug for tough-to-treat form of lung cancer
BioPharma Dive via Yahoo Finance· 4 days agoImdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following...
BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
KTLA-TV Los Angeles· 4 days agoBioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today ...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 1 day agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
Telo Genomics, Emery Pharma Ink Collaboration Agreement
GenomeWeb News· 5 days agoThe collaboration will align Telo's telomere 3D structural biomarker-based platform with Emery's biologic drug development expertise.
What Is The New Treatment Instead of Chemotherapy?
San Diego Red via Yahoo News· 7 days agoAmerica has qualified medical personnel to walk you through your cancer journey, but the prices are out-of-this-world. It’s extremely difficult to find...
Remembering the life of Barbara Coye
Traverse City Record-Eagle· 4 days agoBarbara passed on to the arms of angels May 9, 2024, following what she described as a great life with family, friends, her work, sailing and travel,...
Earnings call: Autolus Therapeutics Reports Progress and Financials for Q1 2024
Investing.com· 4 days agoIn a recent earnings call, Autolus Therapeutics (NASDAQ: AUTL ), a biopharmaceutical company...
